Gibraltar Industries, Canopy Growth, Indivior, Turning Point Brands, Innovative Industrial Properties, Tilray, and Incannex Healthcare are the seven Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis stocks are shares of publicly traded companies operating in the cannabis industry, including businesses that cultivate, process or distribute marijuana, hemp and CBD products. By buying these stocks, investors gain equity exposure to the legal cannabis market and its projected growth potential. Collection of ancillary service providers—such as equipment makers, testing labs or biotech firms—may also trade as cannabis stocks. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.
Gibraltar Industries (ROCK)
Gibraltar Industries, Inc. manufactures and provides products and services for the renewable energy, residential, agtech, and infrastructure markets in the United States and internationally. It operates through four segments: Renewables, Residential, Agtech, and Infrastructure. The Renewables segment designs, engineers, manufactures, and installs solar racking and electrical balance of systems for commercial and distributed generation scale solar installations.
Gibraltar Industries stock traded down $0.42 during mid-day trading on Friday, reaching $59.08. 296,266 shares of the company’s stock were exchanged, compared to its average volume of 229,154. The firm has a market capitalization of $1.74 billion, a PE ratio of 13.22 and a beta of 1.30. The business’s fifty day simple moving average is $56.98 and its 200 day simple moving average is $61.90. Gibraltar Industries has a one year low of $48.96 and a one year high of $81.90.
Read Our Latest Research Report on ROCK
Canopy Growth (CGC)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
Shares of CGC traded down $0.10 during mid-day trading on Friday, hitting $1.83. The stock had a trading volume of 8,142,476 shares, compared to its average volume of 5,823,642. The company has a debt-to-equity ratio of 0.74, a current ratio of 3.52 and a quick ratio of 2.58. Canopy Growth has a 52 week low of $0.77 and a 52 week high of $10.04. The firm has a market cap of $336.47 million, a P/E ratio of -0.48 and a beta of 0.79. The business has a fifty day moving average price of $1.23 and a 200-day moving average price of $2.10.
Read Our Latest Research Report on CGC
Indivior (INDV)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Indivior stock traded up $0.05 during midday trading on Friday, hitting $11.26. 1,303,351 shares of the company’s stock were exchanged, compared to its average volume of 1,022,970. Indivior has a 52-week low of $7.33 and a 52-week high of $18.59. The stock has a 50-day moving average price of $10.27 and a two-hundred day moving average price of $10.70. The company has a market cap of $1.55 billion, a P/E ratio of -32.17 and a beta of 0.98.
Read Our Latest Research Report on INDV
Turning Point Brands (TPB)
Turning Point Brands, Inc., together with its subsidiaries, manufactures, markets, and distributes branded consumer products. The company operates through three segments: Zig-Zag Products, Stoker’s Products, and Creative Distribution Solutions. Zig-Zag Products segment markets and distributes rolling papers, tubes, finished cigars, make-your-own cigar wraps, and related products, as well as lighters and other accessories under the Zig-Zag brand.
Shares of TPB traded up $0.99 during midday trading on Friday, reaching $73.33. The stock had a trading volume of 129,425 shares, compared to its average volume of 170,320. Turning Point Brands has a 12-month low of $30.61 and a 12-month high of $81.05. The company has a current ratio of 4.21, a quick ratio of 1.78 and a debt-to-equity ratio of 1.33. The company’s 50-day moving average is $62.48 and its 200 day moving average is $61.77. The company has a market capitalization of $1.31 billion, a price-to-earnings ratio of 29.10 and a beta of 0.69.
Read Our Latest Research Report on TPB
Innovative Industrial Properties (IIPR)
NYSE IIPR traded down $0.06 on Friday, hitting $55.48. The company’s stock had a trading volume of 147,305 shares, compared to its average volume of 272,139. Innovative Industrial Properties has a 52-week low of $45.44 and a 52-week high of $138.35. The company has a current ratio of 14.32, a quick ratio of 11.53 and a debt-to-equity ratio of 0.16. The company’s 50-day simple moving average is $55.13 and its 200 day simple moving average is $72.59. The firm has a market cap of $1.55 billion, a P/E ratio of 10.03 and a beta of 1.73.
Read Our Latest Research Report on IIPR
Tilray (TLRY)
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.
Shares of NASDAQ:TLRY traded down $0.00 during trading on Friday, hitting $0.44. The stock had a trading volume of 14,619,519 shares, compared to its average volume of 28,289,489. Tilray has a 12 month low of $0.41 and a 12 month high of $2.15. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10. The company has a market capitalization of $445.27 million, a PE ratio of -1.47 and a beta of 1.95. The firm’s fifty day moving average is $0.52 and its 200 day moving average is $0.92.
Read Our Latest Research Report on TLRY
Incannex Healthcare (IXHL)
Incannex Healthcare Inc., a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.
IXHL traded up $0.02 during trading on Friday, hitting $0.22. 26,677,719 shares of the company’s stock traded hands, compared to its average volume of 10,328,279. The stock has a market capitalization of $3.89 million, a price-to-earnings ratio of -0.16 and a beta of 7.67. Incannex Healthcare has a 12-month low of $0.08 and a 12-month high of $3.55. The company has a current ratio of 1.80, a quick ratio of 1.65 and a debt-to-equity ratio of 2.47. The company’s 50 day simple moving average is $0.49 and its two-hundred day simple moving average is $1.31.
Read Our Latest Research Report on IXHL
Further Reading
- MarketBeat’s Top Five Stocks to Own in May 2025
- This Market Sell-Off Might Trigger a Value Rotation Into Pepsi
- Alphabet Stock Lags—But Waymo May Be Its Hidden Driver
- Trade Desk Silences Critics; Recovery Looks Poised to Continue
- Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock
- These ETFs Provide Easy Exposure to Growing International Markets